Natesto Spermatogenesis Reboot

Summary

This is a prospective, non-blinded study of hypogonadal men with a history of testosterone therapy who became azoospermic or severely oligospermic and wish to avoid symptoms of hypogonadism during their recovery of spermatogenesis in an effort to establish paternity. The study will determine if Natesto can alleviate hypogonadal symptoms while preserving the recovery of spermatogenesis

Timeline

Start

2022-06-01

Primary completion

2025-04-21

Completion

2025-04-21

Drugs

Indications